About · The Good Fiber Company

Europe is under-fibered.
We’re fixing that.

GFC is the European authority on dietary fiber for metabolic health. We publish research, we cite our sources, and we’re building a fiber product that actually works for people taking GLP-1 medications.

Founded
2026, Berlin
Locales
EN · DE · ES · FR
Editorial standard
EFSA · DGE · Cochrane
Product
In development
01 · The problem

Not a single European country meets its own fiber guideline.

The European Food Safety Authority recommends at least 25 grams of dietary fiber per day. Germany’s DGE says 30. The British Nutrition Foundation says 30.

Average intake across the continent sits between 16 and 24 grams. Every country, every age bracket, every diet survey we’ve looked at: the gap is real and the gap is consistent1.

Only 3% of European consumers can correctly identify their country’s recommended daily fiber intake2. The gap is not just in diet. It is in awareness.

Adult intake, EU-27 mean
0.0g/day

Roughly five grams below the EFSA floor. In Spain, eight grams below.

EFSA Comprehensive European Food Consumption Database
Can name their guideline
0%

A consumer awareness survey across six EU markets, 2023.

European Consumer Nutrition Survey, n = 6,400

Adult dietary fiber intake across Europe, g/day

Mean intake EFSA 25g
EFSA · 25g
DGE · 30g
DKDenmark
0.0g
NLNetherlands
0.0g
DEGermany
0.0g
ITItaly
0.0g
SESweden
0.0g
GRGreece
0.0g
FRFrance
0.0g
PLPoland
0.0g
UKU.K.
0.0g
ESSpain
0.0g
n = 10 EU countries · adult population mean Source: EFSA Comprehensive Food Consumption Database1
02 · The compound problem

For Europeans on GLP-1s, the gap doesn’t add. It multiplies.

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) reduce appetite. That’s the point. But less food means less fiber, and the high-fiber foods that would help are often the ones that make side effects worse.

STEP 01

GLP-1 starts

Appetite drops. Energy intake falls 20–35% in the first 12 weeks.

STEP 02

Fiber follows

Less food means proportionally less fiber. The 19g average becomes 13–14g.

STEP 03

Side effects appear

Constipation, bloating, slow transit. Affecting 30–40% of users.

STEP 04

High-fiber foods get cut

Whole grains, legumes, raw vegetables. The exact foods that would help.

And the loop closes
Our mission

Science-backed fiber products that are easy to understand, easy to take, and impossible to ignore.

03 · How we work

Three values. Each one is a contract with the reader.

01

Clarity

If people don’t understand fiber, that’s our failure. No jargon. No hype. Every sentence should make the reader smarter, not more confused. We use the generic name first, then the brand in parentheses. We explain the EFSA opinion the way you’d explain it at the dinner table.
02

Substance

Every claim cites a source. Every statistic links to a study. We’d rather say less and be right than say more and be vague. Tier-A sources only: EFSA, EMA, Cochrane reviews, national nutrition bodies. If the evidence isn’t there, we say so on the page.
03

Foresight

We share what we’ve found before it’s obvious. We connect dots others haven’t. The friend who already read the paper. The GLP-1 fiber gap is the example: it was sitting in the literature for two years before anyone in nutrition press wrote about it.

We’re the friend who already read the paper.

The voice, in one line
04 · What we cite

The editorial whitelist. Tier A and Tier B only.

Tier A
EFSA
European Food Safety Authority. Authorized health claims, dietary reference values.
EU
Tier A
EMA
European Medicines Agency. Drug labels for GLP-1 receptor agonists.
EU
Tier A
Cochrane
Systematic reviews of fiber interventions. Highest standard of evidence we cite.
UK / Intl.
Tier B
DGE
Deutsche Gesellschaft für Ernährung. National guideline body, 30g/day recommendation.
DE
Tier B
ANSES
Agence française. National dietary reference values and population intake reporting.
FR
Tier B
BNF
British Nutrition Foundation. Independent charity, public guidance.
UK
Tier B
FEN
Fundación Española de la Nutrición. Spanish population intake data.
ES

We don’t cite influencer blogs, supplement-brand whitepapers, or wellness magazines. If a finding only lives in a press release, it doesn’t reach our pages.

The product is in development.

A fiber supplement designed for GLP-1 users first. EU-made, EFSA-claim compliant, no flavoring theatre. Get the working prototype data and the launch date.